High-fat diet-induced obesity stimulates ketone body utilization in osteoclasts of the mouse bone

Biochemical and Biophysical Research Communications

Volumn 473, Issue 2, 2016, Pages 654-661

  Yamasaki, Masahiro ^a   Hasegawa, Shinya ^a   Imai, Masahiko ^a   Takahashi, Noriko ^a   Fukui, Tetsuya ^a,b  

^a HOSHI UNIVERSITY   (Japan)

^b RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

Acetoacetyl CoA synthetase (AACS); High fat diet; IL 6; Ketone body; Obesity; Osteoclast

Indexed keywords

ACETOACETYL COENZYME A SYNTHASE; ACETYL COENZYME A; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERLEUKIN 6; KETONE BODY; LIPID; MESSENGER RNA; OSTEOCALCIN; SYNTHETASE; UNCLASSIFIED DRUG; ACETOACETYL-COA SYNTHETASE; COENZYME A LIGASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CELL DIFFERENTIATION; CELL LINE RAW 264.7; CONTROLLED STUDY; DIET INDUCED OBESITY; EMBRYO; ENZYME INDUCTION; FEMUR EPIPHYSIS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IN SITU HYBRIDIZATION; LIPID DIET; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; ADVERSE EFFECTS; ANIMAL; BONE; CELL LINE; GENETICS; INFLAMMATION; METABOLISM; MOUSE MUTANT; OBESITY; PATHOLOGY; UPREGULATION;

ANIMALS; BONE AND BONES; CELL LINE; COENZYME A LIGASES; DIET, HIGH-FAT; INFLAMMATION; INTERLEUKIN-6; KETONE BODIES; MALE; MICE; MICE, OBESE; OBESITY; OSTEOCLASTS; RNA, MESSENGER; UP-REGULATION;

EID: 84962130463     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.03.115     Document Type: Article

References (32)

1. C.J. Bailey On the physiology and biochemistry of obesity Sci. Prog. 65 1978 365 393
2. A. Alsahli, K. Kiefhaber, T. Gold, M. Muluke, H. Jiang, S. Cremers, and U. Schulze-Späte Palmitic Acid Reduces Circulating Bone Formation Markers in Obese Animals and Impairs Osteoblast Activity via C16-ceramide Accumulation 2016 Calcif Tissue Int
3. M.A. Bredella, C.M. Gill, A.V. Gerweck, M.G. Landa, V. Kumar, S.M. Daley, M. Torriani, and K.K. Miller Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity Radiology 269 2013 534 541
4. C.J. Edwards, D.J. Hart, and T.D. Spector Oral statins and increased bone-mineral density in postmenopausal women Lancet 355 2000 2218 2219
5. N. Auestad, R.A. Korsak, J.W. Morrow, and J. Edmond Fatty acid oxidation and ketogenesis by astrocytes in primary culture J. Neurochem. 56 1991 1376 1386
6. G.A. Mitchell, S. Kassovska-Bratinova, Y. Boukaftane, M.F. Robert, S.P. Wang, L. Ashmarina, M. Lambert, P. Lapierre, and E. Potier Medical aspects of ketone body metabolism Clin. Invest Med. 18 1995 193 216
7. T. Fukui, M. Ito, and K. Tomita Purification and characterization of acetoacetyl-CoA synthetase from Zoogloea ramigera I-16-M Eur. J. Biochem. 127 1982 423 428
8. M. Ito, T. Fukui, M. Kamokari, T. Saito, and K. Tomita Purification and characterization of acetoacetyl-CoA synthetase from rat liver Biochim. Biophys. Acta 794 1984 183 193
9. G. Endemann, P.G. Goetz, J. Edmond, and H. Brunengraber Lipogenesis from ketone bodies in the isolated perfused rat liver. Evidence for the cytosolic activation of acetoacetate J. Biol. Chem. 257 1982 3434 3440
10. S. Hasegawa, K. Noda, A. Maeda, M. Matsuoka, M. Yamasaki, and T. Fukui Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels Mol. Genet. Metab. 107 2012 553 560
11. S. Hasegawa, Y. Ikeda, M. Yamasaki, and T. Fukui The role of acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, in 3T3-L1 adipocyte differentiation Biol. Pharm. Bull. 35 2012 1980 1985
12. M. Yamasaki, S. Hasegawa, T. Kitani, K. Hidai, and T. Fukui Differential effects of obesity on acetoacetyl-CoA synthetase gene in rat adipose tissues Eur. J. Lipid Sci. Technol. 109 2007 617 622
13. H. Sato, N. Takahashi, M. Nakamoto, M. Ohgami, M. Yamazaki, and T. Fukui Effects of streptozotocin-induced diabetes on acetoacetyl-CoA synthetase activity in rats Biochem. Pharmacol. 63 2002 1851 1855
14. G. Mundy, R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, and G. Gutierrez Stimulation of bone formation in vitro and in rodents by statins Science 286 1999 1946 1949
15. M. Ohnuki, N. Takahashi, M. Yamasaki, and T. Fukui Different localization in rat brain of the novel cytosolic ketone body-utilizing enzyme, acetoacetyl-CoA synthetase, as compared to succinyl-CoA:3-oxoacid CoA-transferase Biochim. Biophys. Acta 1729 2005 147 153
16. I. Miwa, J. Okudo, K. Maeda, and G. Okuda Mutarotase effect on colorimetric determination of blood glucose with -D-glucose oxidase Clin. Chim. Acta 37 1972 538 540
17. Y. Harano, K. Kosugi, T. Hyosu, S. Uno, Y. Ichikawa, and Y. Shigeta Sensitive and simplified method for the differential determination of serum levels of ketone bodies Clin. Chim. Acta 134 1983 327 336
18. S. Botolin, and L.R. McCabe Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice Endocrinology 148 2007 198 205
19. Y.C. Shyng, H. Devlin, and P. Sloan The effect of streptozotocin-induced experimental diabetes mellitus on calvarial defect healing and bone turnover in the rat Int. J. Oral Maxillofac. Surg. 30 2001 70 74
20. J.C. Krakauer, M.J. McKenna, N.F. Buderer, D.S. Rao, F.W. Whitehouse, and A.M. Parfitt Bone loss and bone turnover in diabetes Diabetes 44 1995 775 782
21. M. Ohgami, N. Takahashi, M. Yamasaki, and T. Fukui Expression of acetoacetyl-CoA synthetase, a novel cytosolic ketone body-utilizing enzyme, in human brain Biochem. Pharmacol. 65 2003 989 994
22. R. Narishima, M. Yamasaki, S. Hasegawa, S. Yoshida, S. Tanaka, and T. Fukui Leptin controls ketone body utilization in hypothalamic neuron Neurosci. Lett. 490 2011 185 190
23. S. Kim, I. Sohn, J.I. Ahn, K.H. Lee, and Y.S. Lee Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model Gene 340 2004 99 109
24. C.J. Rosen, and M.L. Bouxsein Mechanisms of disease: is osteoporosis the obesity of bone? Nat. Clin. Pract. Rheumatol. 2 2006 35 43
25. C.A. Lima, A.C. Lyra, R. Rocha, and G.O. Santana Risk factors for osteoporosis in inflammatory bowel disease patients World J. Gastrointest. Pathophysiol. 6 2015 210 218
26. L.J. Raggatt, and N.C. Partridge Cellular and molecular mechanisms of bone remodeling J. Biol. Chem. 285 2010 25103 25108
27. G.R. Mundy Osteoporosis and inflammation Nutr. Rev. 65 2007 S147 S151
28. L. Zhao, S. Zhong, H. Qu, Y. Xie, Z. Cao, Q. Li, P. Yang, Z. Varghese, J.F. Moorhead, Y. Chen, and X.Z. Ruan Chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice Sci. Rep. 5 2015 10222
29. S.L. Teitelbaum Bone resorption by osteoclasts Science 289 2000 1504 1508
30. K.J. Motyl, M. Raetz, S.A. Tekalur, R.C. Schwartz, and L.R. McCabe CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption Am. J. Physiol. Regul. Integr. Comp. Physiol. 300 2011 R1250 R1260
31. K. Mirzaei, A. Hossein-Nezhad, S.M. Eshaghi, H. Ansar, and A. Najmafshar The relationship between obesity and bone mineral density: evidence for a role of peroxisome proliferator-activated receptor gamma Minerva Endocrinol. 40 2015 177 185
32. S. Omoigui Cholesterol synthesis is the trigger and isoprenoid dependent interleukin-6 mediated inflammation is the common causative factor and therapeutic target for atherosclerotic vascular disease and age-related disorders including osteoporosis and type 2 diabetes Med. Hypotheses 65 2005 559 569